NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/08/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.35 mln
Float3.50 mln
Earnings Date05/07/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
4.96
Highly suspicious
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.06
Debt-free
ROE
-115
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Co-Diagnostics is a Salt Lake City-based company that creates and sells testing technology used to detect infectious diseases and other health conditions at the genetic level. Their products cover a wide range of illnesses, including COVID-19, influenza, tuberculosis, hepatitis, and several mosquito-borne diseases, and can be used both in clinical settings and at home. Beyond human health, the company also develops tools for cancer screening and agricultural testing, helping identify specific genetic traits in plants and animals.
